Vaccination against gonadotropin-releasing factor (GnRF) with Bopriva significantly decreases testicular development, serum testosterone levels and physical activity in pubertal bulls.

The aim of this study was to evaluate the effects of vaccination against gonadotropin-releasing factor (GnRF) on testicular development, testosterone secretion, and physical activity in pubertal bulls. The experiment was performed using 44 bulls aged between 6 and 7 mo. Twenty-three animals were vaccinated twice 4 wk apart with 1 mL of Bopriva (Pfizer, Animal Health, Parkville, Australia) and 21 bulls served as matched controls. Serum GnRF antibody titer and testosterone concentration as well as body weight and scrotal circumference were determined in all bulls for 24 wk from the first vaccination. In addition, physical activity was analyzed in 11 vaccinated and in 10 control animals using the ALPRO DeLaval activity meter system (DeLaval AG, Sursee, Switzerland). The results show that vaccination significantly (P < 0.05) influenced all parameters evaluated except body weight. Antibody titers to GnRF began to rise 2 wk after the first vaccination and reached peak values 2 wk after the second injection. Significant group differences in anti-GnRF titer were present for 22 wk following the first vaccination. Testosterone concentrations were significantly lower between weeks 6 to 24 after first vaccination in bulls with Bopriva compared with control animals. In vaccinated bulls testicular development was impaired after the second injection and scrotal circumference was significantly smaller between weeks 8 to 24 after first vaccination. Physical activity of vaccinated bulls was reduced after the booster injection with significant group differences for a continuous period of 106 days. In conclusion, vaccination against GnRF with Bopriva in pubertal bulls decreased testosterone levels in peripheral blood, testicular development, and physical activity but did not affect weight gain.

Effect of vaccination against gonadotropin-releasing factor (GnRF) with Bopriva® in the prepubertal bull calf.

The aim of this study was to evaluate the effect of immunization against gonadotropin-releasing factor (GnRF) with Bopriva(®) (Pfizer Animal Health, Parkville, Australia) in prepubertal bull calves. For the study, 6 calves were vaccinated at the age of 3 and 6 weeks with 1 mL Bopriva(®), and 6 animals served as matched controls. Concentrations of GnRF antibodies, testosterone and LH were determined in serum samples out to 30 weeks after the first immunization. Body weight and scrotal circumference were measured for 59 weeks. At slaughter, 65 weeks after the first immunization, the quality of epididymal sperm was evaluated. The results showed that vaccination against GnRF influenced (P<0.05) anti-GnRF titer, LH and testosterone concentrations as well as scrotal circumference. Antibody titers significantly (P<0.05) increased after the booster vaccination and reached peak values 2 weeks later. Compared to control animals, inhibition (P<0.05) of the prepubertal LH secretion was observed in vaccinated calves at weeks 10 and 12-14 after the first vaccination. In vaccinated calves testosterone concentrations decreased after the booster injection to values below 0.5 ng/mL serum and remained for at least 22 weeks at this low level. Animals vaccinated with Bopriva(®) showed a delay in testes growth and smaller scrotal circumference. Puberty occurred at the age between 46 and 55 weeks in vaccinated and between 38 and 52 weeks in control animals and body weight gain was similar in both groups. All vaccinated bulls attained spermatogenic capacity at slaughter when they were 68 weeks old.

[Transportation of veal calves in Switzerland]. / Schlachtkälbertransporte in der Schweiz.

The analysis and optimization of transportation routes of calves to slaughterhouses by means of a GIS (geographical information system) route planning and time limitation software for the fleet management in transportation industry was performed. As basic data the farms (last locations of the calves) and the slaughterhouses were available in each case with addresses and coordinates. 150 data records from 258 veal calves could be evaluated. None of the calves was transported longer than 6 hours. Therefore, in all cases the Swiss law for animal protection was obeyed concerning maximum length of transportation time. In the road model, 82% of calves were transported too far.

[Investigation of abortions and other animal health problems in relation to vaccination against Bluetongue virus in 2009]. / Abklärung von Aborten und anderen tiergesundheitlichen Problemen beim Rind im Zusammenhang mit der Blauzungenvirus-Impfung 2009.

By the distribution of a questionnaire between all Swiss cattle practitioners it was possible to investigate abortions and other animal health problems related to Bluetongue vaccination 2009. The questionnaire helped to obtain plausibility and timely relation of the reported disorders. 58 abortions in cattle and different herd health problems could be examined. Because there is no possibility to show that a vaccination itself leads to an abortion the results of proven causes of abortions prior and after Bluetongue vaccination were compared regarding their diagnosis. Due to the fact that diagnosis and solving rate of abortions did not differ before and after vaccination, the vaccination itself cannot be responsible for the abortions. Evaluation of different herd health problems showed that Bluetongue vaccination was not responsible for these disorders which often existed already prior to vaccination. Herd health problems generally have multifactorial causes what makes it difficult to asses the effect of Bluetongue vaccination in some cases.

[Ultrasonographic findings and treatment in a cow with a haemangiosarcoma of the urinary bladder]. / Ultraschallbefunde und Therapie bei einer Kuh mit einem Hämangiosarkom in der Harnblase.

A 4.5-year-old Swiss Braunvieh cow was presented to the Department of Farm Animals, University of Zurich, because of severe haematuria. All other clinical findings were within normal ranges. Transrectal ultrasonography revealed a 1 cm x 1 cm echogenic, irregularly-shaped, raised mass in the wall of the urinary bladder. Endoscopy identified the mass as a proliferation, approximately 0.5 cm in diameter, which was bleeding continuously. Thermocautery of the bleeding site was carried out twice five days apart via endoscopy. Clinical signs resolved for the remainder of the cow's life; she was slaughtered 15 months later because of infertility. Histological examination of the mass revealed a haemangiosarcoma.

[Occurrence of biting midges (Culicoides spp.) at three different altitudes in an alpine region of Switzerland]. / Vorkommen von Gnitzen (Culicoides spp.) in drei Höhenlagen einer alpinen Region der Schweiz.

The aim of this field study was to investigate the occurrence of biting midges (Culicoides spp.), the potential vectors of the bluetongue virus (BTV), in an alpine region of Switzerland (Vals/GR) at altitudes between 1300 and 2000 meters above sea level (m a.s.l.). For this purpose, insects were caught with UV-light traps once weekly from the end of June to the end of October 2008. Midges were found on all altitudes investigated, but distinct differences in the abundance at different stations were noticed. Most midges were caught at the intermediate station (about 1500 m a.s.l.) whereas the catches on the two alps (approximately 2000 m a.s.l.) varied considerably. The predominance of midges belonging to the Pulicaris complex, whose vector competence regarding bluetongue virus (BTV) is largely unknown, rose with increasing altitude. To identify potential breeding habitats, 17 soil samples of three farms were incubated in the laboratory. Different insects emerged but none of them was a Culicoides spp. and, therefore, the habitats of juvenile stages remain unknown. From our results we can conclude that most likely there are no midges-free zones in all of the agriculturally utilized areas (including the alpine summer pastures) of Switzerland. This strongly indicates that cattle, sheep, goats and camelids which are permanently or temporarily kept in regions of higher altitude in Switzerland should be vaccinated against bluetongue.

[Hematological and clinical biochemical reference values for adult goats and sheep]. / Hämatologische und klinisch-chemische Referenzwerte für adulte Ziegen und Schafe.

Sheep and goat husbandry has always played an important role in swiss agriculture, but in recent years these animals are increasingly appreciated as hobby pets. This opens new diagnostic and therapeutic perspectives for veterinary surgeons, notably in the determination of hematological and clinical biochemical parameters. For the current methods used there are no reference range values available for adult sheep and goats kept under swiss conditions. Therefore, the present study was designed to determine haematological and clinical biochemical parameters in 102 goats and 102 sheep from swiss flocks. Significant differences were found between the two species, especially regarding erythrocyte count, mean erythrocyte volume, hemoglobin content as well as leukocyte count. It is therefore of utmost importance to discriminate between sheep and goats when interpreting laboratory tween findings.

[Clinical and laryngoscopic findings in a Swiss Alpine goat with left grade 4 laryngeal hemiplegia]. / Klinische und laryngoskopische Befunde bei einer gemsfarbigen Gebirgsziege mit Hemiplegia laryngis sinistra Grad 4.

This case report describes the diagnostic trial of an inspiratory wheeze in a 1.5-year-old Swiss Alpine goat. Left grade 4 laryngeal hemiplegia was diagnosed via laryngoscopy, whereas the severity of the hemiplegia was assessed according to the grading system used in horses. The results of clinical, radiographic, sonographic and endoscopic examinations as well as haematological, biochemical and serological analyses did not reveal the cause of the hemiplegia. Treatment with an antibiotic and vitamin B complex resulted in only slight improvement. A postmortem examination four months later revealed no gross lesions in the left laryngeal nerve, larynx and intrinsic laryngeal musculature. Histological examination of the nerve, arytenoid cartilage and intrinsic laryngeal musculature also showed no lesions. Therefore, the cause of the disease in this goat is suspected to be on the cellular or molecular level of the intrinsic laryngeal musculature.

[Cerebrospinal nematodosis in sheep in Switzerland]. / Zerebrospinale Nematodose beim Schaf in der Schweiz.

In December 2005 three sheep, originating from Canton Tessin, were presented with cerebrospinal nematodosis. The animals had a history of progressive pelvic limb ataxia and recumbency. The most important clinical findings were an abnormal gait (wide stance, pelvic limb paresis) and decreased sensitivity of the pelvic limbs. The general condition was slightly or moderately disturbed, appetite was normal. Examination of the cerebrospinal fluid revealed mononuclear cells and eosinophils, suggesting a helminthic infection of the central nervous system. Postmortem findings confirmed the clinical diagnosis in one animal as parts of a nematode were found in the thoracic spinal cord. Even though the nematode could not be identified, infection with Elaphostrongylus cervi seems very likely, as the sheep are in close contact with deer on the pastures and the parasite is known to infect goats in Switzerland. This is the first description of cerebrospinal nematodosis in sheep in Switzerland.